K. Smeland

Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation

K. H. Hernæs, K. Smeland, U. Fagerli, 2021, BMC cancer.

Survivors’ knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma

Ø. Fluge, K. Smeland, U. Fagerli, 2019, Acta oncologica.

Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation

S. Kvaløy, H. Holte, Ø. Fluge, 2016, Acta oncologica.

Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011–2016

H. Holte, K. Smeland, U. Fagerli, 2020, Acta oncologica.

Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation

K. Smeland, U. Fagerli, C. Kiserud, 2020, BMC cancer.

Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation

S. Fosså, H. Holte, J. Svartberg, 2017, Acta oncologica.

Burkitt Lymphoma International Prognostic Index.

Scott E. Smith, I. Lossos, S. Montoto, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

T. Habermann, H. Holte, K. Smeland, 2020, British journal of haematology.

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study.

H. Holte, M. Bøgsted, M. Jerkeman, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life

F. Mols, K. Smeland, U. Fagerli, 2021, Acta oncologica.

Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation

S. Fosså, H. Holte, J. Svartberg, 2017, Acta oncologica.